Skip to content

Medical Yoga for Patients With Stress-related Symptoms

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02907138
Enrollment
45
Registered
2016-09-20
Start date
2016-09-30
Completion date
2019-03-04
Last updated
2020-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress-related Illness/Anxiety

Brief summary

The purpose of this study is to compare the effect of Medical Yoga as a group treatment, to conventional treatment provided by a physical therapist, for people with perceived stress-related symptoms. Forty people are to be randomized to either: 1. Intervention Group - Medical Yoga, group treatment for eight weeks, 60 minutes per week, with the guidance of a physical therapist. or 2. Control - treatment as usual (TAU) in physical therapy.

Interventions

OTHERTreatment as Usual (physical therapy)

Sponsors

Maria Larsson
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Perceived stress and anxiety, which could be expressed as for example as tension in the neck and shoulders, insomnia, anxiety and headaches.

Exclusion criteria

* Do not understand Swedish (as group instructions need to be understood), * Pregnancy, * Psychotic symptoms, * Ongoing or physical therapy treatment the last three months, * Previously participated in Medical Yoga group.

Design outcomes

Primary

MeasureTime frameDescription
Perceived Stress Scale (PSS)baseline, follow-up at approx 8 weeks after first treatment session, follow-up at approx 20 weeks after first treatment sessionOutcome will be measured as change between baseline and follow-ups and between follow-ups. Total score will also be analysed between groups at follow-up(s).

Secondary

MeasureTime frame
Hospital Anxiety and Depression Scale (HADS)baseline, follow-up at approx 8 weeks after first treatment session, follow-up at approx 20 weeks after first treatment session
Health-related quality of Life; EQ5Dbaseline, follow-up at approx 8 weeks after first treatment session, follow-up at approx 20 weeks after first treatment session
Thorax excursion: Measured in centimeters with tape measure, chest size at the level of processus xiphoideus, the difference between the maximum inhalation and exhalation is registeredbaseline, follow-up at approx 8 weeks after first treatment session, follow-up at approx 20 weeks after first treatment session
Health-related quality of Life; EQ-VASbaseline, follow-up at approx 8 weeks after first treatment session, follow-up at approx 20 weeks after first treatment session

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026